Harfst & Associates Inc. boosted its holdings in shares of Anthem, Inc. (NYSE:ANTM) by 26.9% in the second quarter, HoldingsChannel reports. The firm owned 3,497 shares of the company’s stock after buying an additional 742 shares during the period. Harfst & Associates Inc.’s holdings in Anthem were worth $1,335,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors have also bought and sold shares of the company. Sterling Financial Planning Inc. acquired a new position in Anthem during the second quarter valued at $29,000. Allred Capital Management LLC purchased a new position in Anthem in the first quarter valued at $28,000. Burleson & Company LLC purchased a new position in Anthem in the first quarter valued at $37,000. Bbva USA purchased a new position in Anthem in the second quarter valued at $42,000. Finally, Evoke Wealth LLC increased its holdings in Anthem by 61.3% in the first quarter. Evoke Wealth LLC now owns 121 shares of the company’s stock valued at $43,000 after buying an additional 46 shares in the last quarter. Institutional investors own 86.69% of the company’s stock.
In related news, Director Ryan M. Schneider acquired 1,300 shares of the firm’s stock in a transaction dated Friday, July 23rd. The shares were purchased at an average cost of $384.36 per share, for a total transaction of $499,668.00. Following the acquisition, the director now owns 4,714 shares in the company, valued at approximately $1,811,873.04. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 0.28% of the company’s stock.
Shares of NYSE ANTM opened at $376.90 on Tuesday. Anthem, Inc. has a 12-month low of $244.10 and a 12-month high of $406.00. The stock has a market cap of $91.89 billion, a PE ratio of 22.14, a P/E/G ratio of 1.07 and a beta of 1.03. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.63. The company has a 50-day moving average of $378.73 and a 200 day moving average of $376.87.
Anthem (NYSE:ANTM) last announced its quarterly earnings data on Tuesday, July 20th. The company reported $7.03 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.34 by $0.69. The company had revenue of $33.28 billion during the quarter, compared to analysts’ expectations of $33.22 billion. Anthem had a net margin of 3.27% and a return on equity of 15.24%. Anthem’s revenue was up 14.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned $9.20 EPS. On average, sell-side analysts forecast that Anthem, Inc. will post 25.6 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, September 24th. Shareholders of record on Friday, September 10th will be issued a $1.13 dividend. The ex-dividend date is Thursday, September 9th. This represents a $4.52 annualized dividend and a yield of 1.20%. Anthem’s payout ratio is 20.11%.
Anthem, Inc provides life, hospital and medical insurance plans. It offers a broad spectrum of network-based managed care health benefit plans to the large and small employer, individual, Medicaid, and Medicare markets. The company operates through the following segments: Commercial & Specialty Business, Government Business, IngenioRx and Other.
Recommended Story: Intrinsic Value and Stock Selection
Want to see what other hedge funds are holding ANTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anthem, Inc. (NYSE:ANTM).
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.